A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab

Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.

Detalles Bibliográficos
Autores principales: Kuang, Chaoyuan, Quann, Kevin, Liman, Agnes K., Frye, Roy, Alshoubaki, Nawras, Ramkumar, Mohan, Liman, Andrew D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562843/
https://www.ncbi.nlm.nih.gov/pubmed/33088534
http://dx.doi.org/10.1002/ccr3.3044
_version_ 1783595360599408640
author Kuang, Chaoyuan
Quann, Kevin
Liman, Agnes K.
Frye, Roy
Alshoubaki, Nawras
Ramkumar, Mohan
Liman, Andrew D.
author_facet Kuang, Chaoyuan
Quann, Kevin
Liman, Agnes K.
Frye, Roy
Alshoubaki, Nawras
Ramkumar, Mohan
Liman, Andrew D.
author_sort Kuang, Chaoyuan
collection PubMed
description Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.
format Online
Article
Text
id pubmed-7562843
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75628432020-10-20 A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab Kuang, Chaoyuan Quann, Kevin Liman, Agnes K. Frye, Roy Alshoubaki, Nawras Ramkumar, Mohan Liman, Andrew D. Clin Case Rep Case Reports Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure. John Wiley and Sons Inc. 2020-06-22 /pmc/articles/PMC7562843/ /pubmed/33088534 http://dx.doi.org/10.1002/ccr3.3044 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Kuang, Chaoyuan
Quann, Kevin
Liman, Agnes K.
Frye, Roy
Alshoubaki, Nawras
Ramkumar, Mohan
Liman, Andrew D.
A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
title A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
title_full A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
title_fullStr A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
title_full_unstemmed A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
title_short A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
title_sort rare case of mgrs with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562843/
https://www.ncbi.nlm.nih.gov/pubmed/33088534
http://dx.doi.org/10.1002/ccr3.3044
work_keys_str_mv AT kuangchaoyuan ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT quannkevin ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT limanagnesk ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT fryeroy ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT alshoubakinawras ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT ramkumarmohan ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT limanandrewd ararecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT kuangchaoyuan rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT quannkevin rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT limanagnesk rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT fryeroy rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT alshoubakinawras rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT ramkumarmohan rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab
AT limanandrewd rarecaseofmgrswithimmunotactoidglomerulopathyrespondingtobortezomibdexamethasoneandrituximab

Ejemplares similares